Our analysis, encompassing various cancer types sourced from the TCGA database, has unearthed a compelling relationship between CCL19 expression and cancer suppression, particularly evident in breast cancer (BRCA) and ovarian cancer (OV) cases (Figure 1A, 1B). Here, CCL19 is linked to breast carcinoma.